Theravance Biopharma ( TBPH ) shareholders to receive $17.00 per share in cash, representing an equity value of approximately $929 millionTheravance Biopharma ( TBPH ) shareholders to receive a contingent value right (CVR) entitling them to 80% of net proceeds from any future license, divestiture or other monetization of ampreloxetine within the next ten yearsTransaction follows a comprehensive strategic alternatives...

Acquisition adds YUPELRI® (revefenacin), the first and only approved nebulized long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD to Zymeworks' ( ZYME ) portfolioAcquisition of Theravance Biopharma at $17 per share is supported by an innovative non-recourse financing structure that enhances shareholder value by minimizing Zymeworks’ net capital at risk Transaction expected to be accretive to earnings and...

Combination Will Create a Global Leader in Talent and Organizational Consulting LOS ANGELES--(BUSINESS WIRE)-- Korn Ferry ( KFY ) , a global organizational consulting firm, today announced that it has entered into a definitive agreement with OMERS Private Equity to acquire UK-headquartered AMS, which will create a global leader in talent and organizational consulting. The combination will bring together...

DALLAS--(BUSINESS WIRE)-- San Mateo Midstream, LLC (“San Mateo” or the “Company”), a midstream joint venture between Matador Resources Company (“Matador”) and Five Point Infrastructure (“Five Point”), today announced that it has entered into a definitive agreement to acquire the operating subsidiaries of Cardinal Midstream Partners, LLC (“Cardinal”), a portfolio company of EnCap Flatrock Midstream, for total cash consideration of $752...